TR200302134T4 - 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. - Google Patents

2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.

Info

Publication number
TR200302134T4
TR200302134T4 TR2003/02134T TR200302134T TR200302134T4 TR 200302134 T4 TR200302134 T4 TR 200302134T4 TR 2003/02134 T TR2003/02134 T TR 2003/02134T TR 200302134 T TR200302134 T TR 200302134T TR 200302134 T4 TR200302134 T4 TR 200302134T4
Authority
TR
Turkey
Prior art keywords
thiazolidine
methyl
dicarboxylic acid
acceptable salts
physiologically acceptable
Prior art date
Application number
TR2003/02134T
Other languages
English (en)
Inventor
Susilo Rudy
Rommelspacher Hans
Original Assignee
Dr. Rudy Susilo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Rudy Susilo filed Critical Dr. Rudy Susilo
Publication of TR200302134T4 publication Critical patent/TR200302134T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/426—1,3-Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Bulus konusu kanserlerin tedavisinde ve/veya önlenmesinde 2-metil-tiazolidin-2,4-dikarboksilik asit (2-MTDC) ve/veya bunun fizyolojik olarak uygun tuzlarinin kullanimina iliskindir.
TR2003/02134T 2000-02-15 2001-02-15 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı. TR200302134T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10008159A DE10008159B4 (de) 2000-02-15 2000-02-15 Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Publications (1)

Publication Number Publication Date
TR200302134T4 true TR200302134T4 (tr) 2004-01-21

Family

ID=7631906

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2003/02134T TR200302134T4 (tr) 2000-02-15 2001-02-15 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.

Country Status (15)

Country Link
US (2) US6943185B2 (tr)
EP (1) EP1255538B1 (tr)
JP (1) JP2003522782A (tr)
CN (1) CN1400899A (tr)
AT (1) ATE252383T1 (tr)
AU (1) AU783933B2 (tr)
CA (1) CA2399709C (tr)
DE (2) DE10008159B4 (tr)
EA (1) EA004592B1 (tr)
ES (1) ES2208571T3 (tr)
MX (1) MXPA02007903A (tr)
PL (1) PL357179A1 (tr)
PT (1) PT1255538E (tr)
TR (1) TR200302134T4 (tr)
WO (1) WO2001060343A2 (tr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050197406A1 (en) * 1999-04-14 2005-09-08 Li Chiang J. Method of treatment of lung cancer
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel
ZA200502495B (en) * 2002-02-28 2005-09-20 Japan Tobacco Inc Ester compound and medicinal use thereof.
EP1669345A4 (en) * 2003-08-29 2008-02-20 Japan Tobacco Inc ESTER DERIVATIVE AND MEDICAL USE THEREOF
DE102004021658A1 (de) * 2004-05-03 2005-12-01 Rudy Dr. Susilo Kombinationspräparate enthaltend 2-Methylthiazolidin-2,4-dicarbonsäure
US20060030623A1 (en) * 2004-07-16 2006-02-09 Noboru Furukawa Agent for the treatment or prevention of diabetes, obesity or arteriosclerosis
US8101774B2 (en) * 2004-10-18 2012-01-24 Japan Tobacco Inc. Ester derivatives and medicinal use thereof
CA2582767C (en) * 2004-10-25 2011-05-24 Japan Tobacco Inc. Solid formulation with improved solubility and stability and method for producing said formulation
JP5439849B2 (ja) * 2008-02-28 2014-03-12 味の素株式会社 システイン誘導体
JP5378713B2 (ja) * 2008-06-19 2013-12-25 日本理化学薬品株式会社 外用組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19711052C2 (de) * 1997-03-03 1999-09-23 Hans Rommelspacher Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure als Mukolytikum
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
DE10008159B4 (de) * 2000-02-15 2005-08-18 Rudy Dr. Susilo Verwendung von 2-Methyl-thiazolidin-2,4-dicarbonsäure und/oder ihrer physiologisch verträglichen Salze als Antikrebsmittel

Also Published As

Publication number Publication date
DE10008159A1 (de) 2001-09-06
DE10008159B4 (de) 2005-08-18
ATE252383T1 (de) 2003-11-15
CA2399709A1 (en) 2001-08-23
CN1400899A (zh) 2003-03-05
US6943185B2 (en) 2005-09-13
US20050187271A1 (en) 2005-08-25
PT1255538E (pt) 2004-03-31
ES2208571T3 (es) 2004-06-16
AU3919001A (en) 2001-08-27
EA200200853A1 (ru) 2003-02-27
US20030149085A1 (en) 2003-08-07
DE50100833D1 (de) 2003-11-27
EP1255538A2 (de) 2002-11-13
CA2399709C (en) 2007-05-15
WO2001060343A2 (de) 2001-08-23
MXPA02007903A (es) 2004-09-10
EP1255538B1 (de) 2003-10-22
WO2001060343A3 (de) 2002-05-30
EA004592B1 (ru) 2004-06-24
AU783933B2 (en) 2005-12-22
PL357179A1 (en) 2004-07-26
JP2003522782A (ja) 2003-07-29

Similar Documents

Publication Publication Date Title
MXPA03007140A (es) Derivados de carbolina.
SE0102315D0 (sv) Compounds
MY135766A (en) Quinolinones and naphthyridinones for treating inflammatory diseases
TR200103493T2 (tr) Metaloproteaz önleyicileri
TR200302242T2 (tr) Protein kinaz önleyicileri olarak pirolopirimidinler
BR0108396A (pt) Derivados de pirimidina-4-0na como inibidores de ldl-pla(2)
ATE508735T1 (de) Pulmonale verabreichung von aminoglykosiden
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
DE60216233D1 (en) Carbolinderivate
MXPA03010761A (es) Combinaciones farmaceuticas.
MXPA03002911A (es) Compuestos quimicos.
DE60112306D1 (de) Kondensierte pyrazindionderivate als pde5 inhibitore
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
MXPA04001256A (es) Productos de combinacion de derivados de propanolamina aril substituidos con otros ingredientes activos y su uso.
TR200302134T4 (tr) 2-metil-tiazolidin-2,4-dikarboksilik asit ve/veya bunun fizyolojik olarak uygun tuzlarının anti-kanser ajanları olarak kullanımı.
DE60112960D1 (de) Kondensierte pyridoindolderivate
ATE333457T1 (de) Zyklische gmp-spezifische phosphodiesteraseinhibitoren
TR200402070T4 (tr) Siklobüten-dion türevleri ve bunların damar sertliği tedavisinde kullanımı
EE200300129A (et) Distamütsiini alfa-halogenoakrüloüülderivaadi kasutamine
DE60122559D1 (de) Indolderivate als pde5-inhibitoren
SE0001916D0 (sv) Novel formulation
DE60110124D1 (de) Kondensierte pyrazindionderivate als pde inhibitoren
DE60131968D1 (de) PYRANOÄ2,3-cÜIMIDAZOÄ1,2-aÜPYRIDIN-DERIVATE ZUR BEHANDLUNG VON GASTROINTESTINALEN ERKRANKUNGEN
BR0111785A (pt) Composições e métodos para tratamento de candidìase
ATE330958T1 (de) Pyrazino 1'2':1,6öpyrido 3,4-böindolderivate